This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sonoma Orthopedic Products (Sonoma) Announced The Addition Of Three Executives Today

CHICAGO, April 24, 2013 /PRNewswire/ -- "These proven performers were hired to drive our value proposition of revolutionizing fracture healing approaches to deliver a substantially better quality of life for patients than current treatment options," said Rick Epstein, CEO of Sonoma. "As part of our already strong team, they will help fulfill the proposition through strategy, solid clinical evidence and inspired product design."

Victoria Good, PhD, recently joined Sonoma as Director of Clinical Affairs. She will be responsible for orchestrating clinical studies and publication efforts to demonstrate the unique advantages of Sonoma's intramedullary implants. Victoria comes to Sonoma with over 16 years of experience in orthopedics and clinical studies. Additionally, she has authored over 50 medical device publications. Her resume includes work with Smith and Nephew, Covidien, and Carl Zeiss Meditec.

Alex Winber has accepted the position of Vice President of Marketing. He will play a key role in communicating the exceptional benefits that our products and minimally invasive procedures offer fracture patients along with creating patient education programs for surgeon customers. Alex comes to Sonoma from Wright Medical Technology, after 16 years of experience there, where he led the commercialization of several important and successful technologies, ranging from computer-derived surgical navigation to a micro-invasive hip replacement technique.

Kyle Lappin has joined Sonoma as Director of Research and Development. He will lead new product development activities for forthcoming implants and procedures, and he will also be optimizing existing product offerings. Kyle has been a highly regarded orthopedic design engineer for the past ten years who amassed over 20 patents and patent applications at Wright Medical Technology, Biomet, and DePuy. Kyle has spent the past 5 1/2 years working in the Shoulders division at DePuy, where he has become recognized as an expert in shoulder surgery and instrumentation design by his peers and renowned surgeons, worldwide.

Kyle, Alex and Victoria are relocating to the new Sonoma headquarters, in the Chicago suburbs.

About the Company:  Sonoma Orthopedic Products is a private medical device company focused on designing, developing, and marketing unique minimally invasive fracture healing products. Sonoma Orthopedic Products developed the proprietary WaviBody technology that allows intramedullary nails to convert from flexible-to-rigid within the bone. Recent studies and patient surveillance demonstrates that distal radius fragility fracture patients and clavicle fracture patients implanted with Sonoma products recover faster, with less pain, and a higher likelihood of regaining normal function than alternative surgical and non-surgical treatment options. Additionally, clavicle patients implanted with the Sonoma product are 95% less likely to have their device removed due to discomfort, than patients whose fractures are repaired with clavicle plates. Sonoma patients also report a more satisfying cosmetic result than alternative surgical options. The company currently markets the CRx clavicle fracture repair device, the WRx wrist fracture repair device, and the HMRx humerus fracture repair device. 

Sonoma Orthopedic Products was founded in 2005, and is headquartered in Buffalo Grove, Illinois. For more information, visit http://www.sonomaorthopedics.com/

Contact:  Alex WinberVice President of Marketing(707) 526-1335 press@sonomaorthopedics.com



1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,131.97 +100.83 0.59%
S&P 500 1,998.98 +14.85 0.75%
NASDAQ 4,552.7590 +33.8570 0.75%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs